Neurizon Therapeutics Limited (ASX:NUZ)
Australia
· Delayed Price · Currency is AUD 0.0850
-0.0020 (-2.30%)
Apr 29, 2026, 3:47 PM AEST
Neurizon Therapeutics Market Cap
Neurizon Therapeutics has a market cap or net worth of 64.56 million as of April 28, 2026. Its market cap has increased by 24.90% in one year.
Market Cap
64.56M
Enterprise Value
58.24M
Revenue
5.98M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.09
Market Cap Chart
Since September 12, 2002, Neurizon Therapeutics's market cap has increased from 4.18M to 64.56M, an increase of 1,443.36%. That is a compound annual growth rate of 12.27%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Prescient Therapeutics | 57.31M |
| Entropy Neurodynamics | 56.30M |
| Radiopharm Theranostics | 70.88M |
| LTR Pharma | 78.16M |
| Cynata Therapeutics | 80.73M |
| Botanix Pharmaceuticals | 81.61M |
| Amplia Therapeutics | 84.66M |
| Paradigm Biopharmaceuticals | 88.10M |